The mission of the Madison, Wisconsin-based International Breast Cancer Research Foundation (IBCRF) (1993–2015) was to pursue cost-effective, clinical research with the aim of alleviating the difficult circumstances of women throughout the world. Peer-reviewed research at the organization was funded by the

National Institutes of Health The National Institutes of Health, commonly referred to as NIH (with each letter pronounced individually), is the primary agency of the United States government responsible for biomedical and public health research. It was founded in the late ...

, The

Susan G. Komen Foundation Susan G. Komen (formerly known as Susan G. Komen for the Cure; originally as The Susan G. Komen Breast Cancer Foundation; often simply as Komen) is a breast cancer organization in the United States. Komen focuses on patient navigation and advo ...

, and the

Breast Cancer Research Foundation The Breast Cancer Research Foundation (BCRF) is an independent, not-for-profit organization which has raised $569.4 million to support clinical and translational research on breast cancer at medical institutions in the United States and abroad. BC ...

. Changes in the National Institutes of Health/

National Cancer Institute The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. ...

funding rules for international projects, however, rendered the organization's mission untenable. As a consequence, the organization’s board and scientific director agreed to close the organization on July 1, 2015. Following closure, the IBCRF tissues sample bank was given at no cost to the

University of North Carolina The University of North Carolina is the multi-campus public university system for the state of North Carolina. Overseeing the state's 16 public universities and the NC School of Science and Mathematics, it is commonly referred to as the UNC Sy ...

, Breast Cancer Research Program. During its 22-year tenure, the IBCRF was recognized for its high ethical standards of research. In 1997, Scientific Director Dr. Richard R. Love was awarded the Westerman Prize in Clinical Research Ethics by the American Federation for Medical Research. Results of the organization’s recent major clinical research activities were published in the following major scientific peer-reviewed articles: *Love, R.R., Young, G.S., Laudico, A.V., Dinh, N.V. et al. : ''Bone mineral density changes following surgical oophorectomy and tamoxifen adjuvant therapy for operable breast cancer in pre-menopausal Filipino and Vietnamese women.'' Cancer 2013; 119:3746-52. *Love, R.R., Laudico, A.V., Dinh, N.V. et al.: ''Timing of adjuvant surgical oophorectomy in the menstrual cycle and disease-free and overall survival in premenopausal women with operable breast cancer.'' Journal of the National Cancer Institute 2015 107 (3): djv064 doi: 10.1093/jnci/djv064 *Love, R. R., Hossain, S.M., Hussain, M. et al.: ''Luteal versus follicular phase surgical oophorectomy plus tamoxifen in premenopausal women with metastatic hormone receptor positive breast cancer.'' Euro J Cancer 2016. 60:107-116. https://dx.doi.org/10.1016/j.ejca.2016.03.011 *Love, R.R., Ferdousy, T., Paudel, B.D., Nahar, S., Dowla, R., Adibuzzaman, M., Ahsan, G.M.T., Uddin, M., Salim, R., and Ahamed, S.I.: ''Symptom levels in care-seeking Bangladeshi and Nepalese adults with advanced cancer.'' J Global Oncology July 27, 2016, doi:10.1200/JGO.2016.004119 *Love, R.R.: ''Adjuvant surgical oophorectomy plus tamoxifen in premenopausal women with operable breast cancer: a global treatment option.'' Clin Breast Cancer 2016.16: 233-7. https://dx.doi.org/10.1016/j.clbc.2016.03.003. *Hart, C.D.*, Tenori, L.*, Vignoli, A., Uy, G., To, V.T., Adebamowo, C., Biganzoli, L. Risi, E., Love, R.R.**, Luchinat, C.,**, Di Leo, A.** (*Co-first authors; **Co-senior authors) ''Serum metabolomic profiles identify early breast cancer patients at increased risk of disease recurrence in a multicenter population.'' Clinical Cancer Research 2017. DOI: 10.1158/1078-0432.CCR-16-1153

References

{{reflist Breast cancer organizations Organizations established in 1993 Organizations disestablished in 2015 Cancer charities in the United States